Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 Supplementation in Early-stage Severe COVID-19
NCT06585995Completed
- Sponsor
- Escuela Militar de Graduados de Sanidad
- Start
- Apr 2022
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised trial of vitamin d in coronavirus disease 2019 (COVID-19), sponsored by Escuela Militar de Graduados de Sanidad. Primary endpoints: Glutathione Peroxidase Activity at Day 14, Serum 25-Hydroxyvitamin D Levels at Day 14 and 1 more. Started Apr 2022; status: completed.
02
Drugs
vitamin d
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06585995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06585995.